Porvair (LON:PRV) Stock Rating Reaffirmed by Shore Capital

Shore Capital restated their hold rating on shares of Porvair (LON:PRVFree Report) in a research note issued to investors on Monday morning, Marketbeat reports.

Separately, Berenberg Bank began coverage on shares of Porvair in a research note on Thursday, May 16th. They issued a buy rating and a GBX 800 ($10.12) target price for the company.

View Our Latest Report on Porvair

Porvair Price Performance

Shares of LON PRV opened at GBX 652.13 ($8.25) on Monday. The firm has a market cap of £302.33 million, a PE ratio of 1,834.29 and a beta of 0.76. The company has a current ratio of 2.22, a quick ratio of 1.22 and a debt-to-equity ratio of 11.52. Porvair has a 1-year low of GBX 522 ($6.60) and a 1-year high of GBX 745.70 ($9.43). The company has a fifty day moving average price of GBX 658.40 and a 200 day moving average price of GBX 641.73.

Porvair Cuts Dividend

The firm also recently declared a dividend, which will be paid on Wednesday, August 21st. Shareholders of record on Thursday, July 18th will be given a dividend of GBX 2.10 ($0.03) per share. The ex-dividend date is Thursday, July 18th. This represents a yield of 0.32%. Porvair’s dividend payout ratio (DPR) is presently 1,714.29%.

Insiders Place Their Bets

In other Porvair news, insider James Mills purchased 4,250 shares of the business’s stock in a transaction on Friday, April 19th. The shares were purchased at an average cost of GBX 620 ($7.84) per share, with a total value of £26,350 ($33,329.12). Insiders own 22.91% of the company’s stock.

Porvair Company Profile

(Get Free Report)

Porvair plc engages in the filtration, laboratory, and environmental technology business. It operates through three segments: Aerospace & Industrial, Laboratory, and Metal Melt Quality. The Aerospace & Industrial segment designs and manufactures a range of specialist filtration equipment for aerospace, energy, and industrial applications.

Further Reading

Receive News & Ratings for Porvair Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Porvair and related companies with MarketBeat.com's FREE daily email newsletter.